Ixaka
Alberto del Pino Zumaquero is an experienced professional in the field of biomedicine and biotechnology. Currently serving as an Analytical Development Specialist at Ixaka since May 2018, Alberto previously held roles including Quality Control and Assay Development. Alberto worked as a Stem Cell Culture Specialist at GENyO from June to October 2017 and as a Biobank Technician at Fundación Progreso y Salud from January 2012 to April 2017. Alberto’s academic background includes a Master’s degree in Manufacturing of Advanced Therapy Medicinal Products with a specialization as a Qualified Person from Universidad de Granada, along with another Master’s degree in Biotechnology from the same institution. Alberto completed a Licenciatura in Biology at Universidad de Jaén.
This person is not in any offices
Ixaka
1 followers
Ixaka is a private UK-based cell and gene therapy company with operations in the UK, Spain and France. The company is focused on the natural power of the body to cure disease. Our proprietary technologies enhance the inherent therapeutic power of cells by targeting curative cells to the site of disease and by directly modifying cells within the body to improve their therapeutic action. Ixaka’s technologies – concentrated multi-cell therapies and targeted nano-particles – demonstrate potential for the treatment of a broad range of serious diseases across oncology, cardiovascular, neurological and ocular diseases, and genetic disorders.